STRATA Skin Sciences, Inc. (SSKN) Income Statement
SSKN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsSSKN revenue and net income
Where SSKN's revenue goes
2025Each bar shows an amount and its share of revenue. SSKN kept −20.4% of revenue as net income.
SSKN profit margins
SSKN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −8.5% | −5.3% | +5.9% | +5.2% |
| Gross profit | −6.3% | −6.3% | +4.8% | +14.1% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SSKN quarterly EPS vs estimates
STRATA Skin Sciences beat the analyst EPS estimate in 1 of the last 8 quarters.
SSKN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.7M | $33.6M | $33.4M | $36.2M | $30.0M | $23.1M | $31.6M | $29.9M | $31.4M | $31.8M |
| Cost of revenue | $12.8M | $14.5M | $14.9M | $14.4M | $10.1M | $9.0M | $11.3M | $12.7M | $13.5M | $12.6M |
| Gross profit | $17.9M | $19.1M | $18.5M | $21.8M | $19.9M | $14.1M | $20.3M | $17.1M | $18.0M | $19.1M |
| Research & development | $421,000 | $883,000 | $1.3M | $1.0M | $1.4M | $1.3M | $1.0M | $1.1M | $1.7M | $1.9M |
| Sales, general & admin | $23.3M | $23.6M | $23.5M | $25.4M | $22.8M | $16.9M | $22.3M | $19.4M | $18.6M | $20.8M |
| Total operating expenses | $23.7M | $28.3M | $27.1M | $26.4M | $24.3M | $18.2M | $23.3M | $20.5M | $20.4M | $22.7M |
| Operating income | −$5.8M | −$9.3M | −$8.6M | −$4.6M | −$4.4M | −$4.1M | −$3.0M | −$3.4M | −$2.4M | −$3.6M |
| Interest income | $410,000 | $242,000 | $192,000 | $89,000 | $15,000 | $150,000 | $515,000 | $1.1M | $557,000 | $496,000 |
| Interest expense | $2.0M | $2.1M | $1.6M | $926,000 | $314,000 | $211,000 | $515,000 | $0 | $3.2M | $4.9M |
| Income before taxes | −$6.2M | −$10.3M | −$10.9M | −$5.5M | −$2.7M | −$4.1M | −$3.9M | −$4.3M | −$18.7M | −$3.1M |
| Income taxes | $12,000 | −$170,000 | −$92,000 | $63,000 | $34,000 | $275,000 | −$149,000 | −$264,000 | $129,000 | $255,000 |
| Net income | −$6.3M | −$10.1M | −$10.8M | −$5.5M | −$2.7M | −$4.4M | −$3.8M | −$4.0M | −$21.5M | −$3.3M |
| EBITDA | $177,000 | −$2.8M | −$3.4M | $1.1M | $1.7M | −$15,000 | $1.8M | $2.0M | $4.5M | $2.8M |
| EPS (diluted) | −$1.06 | −$3.90 | −$1.83 | −$1.50 | −$1.20 | −$1.21 | $0.46 | −$5.17 | −$70.61 | −$21.45 |
| Gross margin | 58.3% | 56.9% | 55.3% | 60.2% | 66.2% | 61.2% | 64.2% | 57.3% | 57.1% | 60.2% |
| Operating margin | −19.0% | −27.6% | −25.8% | −12.9% | −14.7% | −17.7% | −9.5% | −11.2% | −7.7% | −11.3% |
| Net margin | −20.4% | −30.1% | −32.5% | −15.3% | −9.0% | −19.1% | −12.0% | −13.5% | −68.4% | −10.5% |
| Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.3M | $6.9M | $7.7M | $6.8M | $9.6M | $8.8M | $8.4M | $6.8M | $8.7M | $8.9M | $8.2M | $7.6M |
| Cost of revenue | $3.7M | $2.7M | $3.4M | $3.2M | $3.8M | $3.5M | $3.5M | $3.7M | $3.9M | $3.9M | $3.9M | $3.2M |
| Gross profit | $5.6M | $4.2M | $4.3M | $3.6M | $5.8M | $5.3M | $4.9M | $3.1M | $4.8M | $5.0M | $4.3M | $4.4M |
| Research & development | $67,000 | $172,000 | $86,000 | $96,000 | $200,000 | $243,000 | $199,000 | $241,000 | $380,000 | $248,000 | $374,000 | $315,000 |
| Sales, general & admin | $5.5M | $5.9M | $6.4M | $5.6M | $5.9M | $6.7M | $5.2M | $5.7M | $5.6M | $5.3M | $5.9M | $6.7M |
| Total operating expenses | $5.6M | $6.0M | $6.5M | $5.7M | $10.0M | $7.0M | $5.4M | $6.0M | $8.2M | $5.6M | $6.3M | $7.0M |
| Operating income | $37,000 | −$1.9M | −$2.2M | −$2.0M | −$4.2M | −$1.7M | −$486,000 | −$2.9M | −$3.4M | −$615,000 | −$2.0M | −$2.6M |
| Interest income | $66,000 | $49,000 | $226,000 | $69,000 | $75,000 | $68,000 | $54,000 | $45,000 | $83,000 | $90,000 | $21,000 | $37,000 |
| Interest expense | $484,000 | $498,000 | $491,000 | $486,000 | $515,000 | $537,000 | $531,000 | $524,000 | $528,000 | $528,000 | $298,000 | $286,000 |
| Income before taxes | $70,000 | −$1.6M | −$2.5M | −$2.4M | −$4.7M | −$2.1M | −$99,000 | −$3.4M | −$3.9M | −$1.1M | −$3.1M | −$2.8M |
| Income taxes | $12,000 | — | — | −$170,000 | −$170,000 | — | — | −$92,000 | −$92,000 | −$1.5M | $298,000 | $535,000 |
| Net income | $58,000 | −$1.6M | −$2.5M | −$2.4M | −$4.5M | −$2.1M | −$99,000 | −$3.4M | −$3.8M | −$1.1M | −$3.1M | −$2.8M |
| EBITDA | $943,000 | −$173,000 | −$693,000 | −$641,000 | −$2.8M | −$265,000 | $1.8M | −$1.5M | $214,000 | $1.0M | −$1.4M | −$1.0M |
| EPS (diluted) | — | −$0.36 | −$0.60 | −$0.58 | $0.29 | −$0.52 | −$2.75 | −$0.92 | −$0.11 | −$0.29 | −$0.63 | −$0.80 |
| Gross margin | 60.4% | 60.4% | 56.2% | 53.5% | 60.1% | 60.3% | 58.5% | 45.6% | 55.3% | 56.0% | 52.3% | 58.0% |
| Operating margin | 0.4% | −26.8% | −29.0% | −29.6% | −44.1% | −18.8% | −5.8% | −42.8% | −39.6% | −6.9% | −23.8% | −34.2% |
| Net margin | 0.6% | −23.4% | −32.5% | −35.7% | −47.0% | −24.1% | −1.2% | −49.9% | −43.7% | −11.9% | −38.2% | −37.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SSKN's financial statements (latest annual report filed March 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SSKN financial results
In fiscal year 2025 (ended December 31, 2025), STRATA Skin Sciences reported revenue of $30.7 million, down 8.5% from the year before. It had a net loss of $6.3 million, a net profit margin of −20.4%. Diluted earnings per share came to −$1.06. Over five years revenue grew at an average rate of 5.9% a year.
See the SSKN stock overview for the latest quote and news, or the SSKN chart for price history and technical indicators.
SSKN income statement FAQ
What is STRATA Skin Sciences's annual revenue?
STRATA Skin Sciences reported total revenue of $30.7 million for fiscal year 2025, which ended on December 31, 2025. That was down 8.5% from $33.6 million the previous year.
Is STRATA Skin Sciences profitable?
No. STRATA Skin Sciences reported a net loss of $6.3 million in fiscal 2025, a net profit margin of −20.4%; its operating margin was −19.0%.
What is STRATA Skin Sciences's gross margin?
STRATA Skin Sciences's gross margin was 58.3% in fiscal 2025: for every $100 of revenue, STRATA Skin Sciences kept $58 after the direct cost of its products and services.
How much does STRATA Skin Sciences spend on research and development?
STRATA Skin Sciences spent $0.4 million on research and development in fiscal 2025, 1.4% of revenue.
How fast is STRATA Skin Sciences growing?
Revenue grew 5.9% a year on average over the last five fiscal years, from $23.1 million to $30.7 million.
What are STRATA Skin Sciences's earnings per share?
STRATA Skin Sciences earned $-1.06 per diluted share in fiscal 2025, compared with $-3.90 a year earlier.
When does STRATA Skin Sciences's fiscal year end?
STRATA Skin Sciences's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 26, 2026.